Is a complete TARA research report available?

No complete published report is available for Protara Therapeutics, Inc. (TARA) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Protara Therapeutics, Inc. (TARA)

NASDAQ: TARA · USD

$4.03

+0.22 (+5.8%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first TARA analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	226.5M
Net income (ttm)	-63.3M
EPS (ttm)	-$1.35
Shares out	56.2M
Volume	273,093
Beta	1.48
Price target	$26.6	+559.3%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -63.3M
EPS (ttm): -$1.35
Market cap: 226.5M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All TARA indicators

Market & fundamental data

Available fields

179

Groups with data

Currency

USD

Showing 179 of 179 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001359931
Company name	Protara Therapeutics, Inc.
Country	United States
Country code	US
Cusip	74365U107
Employees	46
Employees Change	18%
Employees Change Percent	64.29
Enterprise value	$52.1M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US74365U1079
Last refreshed	2026-07-31
Market cap	$226.5M
Market cap category	Micro-Cap
Price	$4.03
Price currency	USD
Sector	Healthcare
Sector PE	45.51
Sector PE Fwd	24.23
Sic	2836
Symbol	TARA
Website	https://www.protaratx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-27.95%
FCF yield	-27.83%
P/B ratio	1.22x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-63.3M
Net Income Growth Years	0%
Profit Per Employee	$-1.4M
ROA	-24.29
Roa5y	-20.96
ROCE	-38.28
ROE	-37.27
Roe5y	-38.61
ROIC	-25.24

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	21.04%
Cagr3y	16.33%
Cagr5y	-12.92%
EPS Growth Years	3
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$191.9M
Cash	$135.8M
Current Assets	$140M
Current Liabilities	$8.9M
Debt	$3.1M
Debt Equity	$0.02
Equity	$181.2M
Liabilities	$10.7M
Long Term Assets	$51.9M
Long Term Liabilities	$1.8M
Net Cash	$174.4M
Net Cash By Market Cap	$76.98
Net Cash Growth	13.75%
Net Debt Equity	$-0.96
Tangible Book Value	$181.2M
Tangible Book Value Per Share	$3.29
WACC	12.22

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	15.69
Net Working Capital	$-3.4M
Quick ratio	15.39
Working Capital	$131.1M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-68.53%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	21.02%
200-day SMA	5.29
3Y total return	57.42%
50-day SMA	4.18
50-day SMA vs 200-day SMA	50under200
5Y total return	-49.94%
All Time High	67.08
All Time High Change	-93.99%
All Time High Date	2020-06-03
All Time Low	1.04
All Time Low Change	287.5%
All Time Low Date	2023-11-22
ATR	0.2
Beta	1.48
Beta1y	0.77
Beta2y	0.78
Ch YTD	-24.39
High	4.05
High52	7.82
High52 Date	2025-11-24
High52ch	-48.47%
Low	3.77
Low52	2.97
Low52 Date	2025-08-20
Low52ch	35.69%
Ma50ch	-3.47%
Premarket Change Percent	1.05
Premarket Price	$3.85
Premarket Volume	340
Price vs 200-day SMA	-23.85%
RSI	47.45
RSI Monthly	47.4
RSI Weekly	39.58
Sharpe ratio	0.59x
Sortino ratio	0.99
Total Return	-68.53%
Tr YTD	-24.39
Tr1m	-3.12%
Tr1w	-0.25%
Tr3m	-22.05%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	8
Analyst Count Top	7
Analyst Price Target Top	$26
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.32
Operating Income	$-70.1M
Price target	$26.57
Price Target Change	$559
Price Target Change Top	$545

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	49,157,486%
Float Percent	87.46%
Shares Insiders	1.8%
Shares Institutions	70.64%
Shares Out	56,204,237
Shares Qo Q	24.97%
Shares Yo Y	68.53%
Short Float	9.24%
Short Ratio	5.96
Short Shares	8.08

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-67.4M
Adjusted OCF	-67,350,000
Average Volume	498,181.05x
Bv Per Share	3.29
CAPEX	$-50,000
Ch1m	-3.12
Ch1w	-0.25
Ch1y	21.02
Ch3m	-22.05
Ch3y	57.42
Ch5y	-49.94
Ch6m	-42.43
Change	5.77%
Change From Open	6.05
Close	3.81
Days Gap	-0.26
Depreciation Amortization	369,000
Dollar Volume	1,100,564.8
Earnings Date	2026-08-13
Earnings Time	bmo
EBIT	$-70.1M
EBITDA	$-69.7M
EPS	$-1.35
F Score	1
FCF	$-63M
FCF EV Yield	-120.93x
FCF Per Share	$-1.12
Financing CF	82,129,000
Fiscal Year End	December
Investing CF	-95,858,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-13
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-10
Ma150	5.16
Ma150ch	-21.9%
Ma20	4.09
Ma20ch	-1.37%
Net CF	-76,724,000
Next Earnings Date	2026-08-10
Open	3.8
Optionable	Yes
Position In Range	94.53
Ppne	3,560,000
Pre Close	3.81
Price Date	2026-07-30
Ptbv Ratio	1.25
Relative Volume	0.55x
Share Based Comp	4,355,000
Tr6m	-42.43%
Us State	New York
Volume	273,093

Protara Therapeutics, Inc. (TARA)

Coverage state: Market snapshot only — no published research

Generate the first TARA analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · TARA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TARA indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on TARA

Frequently asked questions